M. Moriyama

发表

Antenatal diagnosis and in utero treatment of fetal arrhythmia.

K. Iida, T. Hata, K. Hata, 2010, Asia-Oceania journal of obstetrics and gynaecology.

Thymidine kinase in epithelial ovarian cancer: Relationship with the other pyrimidine pathway enzymes

H. Katabuchi, K. Nakayama, H. Okamura, 2002, International journal of cancer.

Clinical Value of Thymidine Kinase in Patients with Cervical Carcinoma

H. Katabuchi, H. Okamura, K. Miyazaki, 2001, Oncology.

Effect of anaesthetic agents on the phagocytic function of human polymorphonuclear leukocytes through analysis with a phagocytic plaque method

S. Toyota, Y. Amaki, K. Seki, 1995, Inflammation Research.

Clinical usefulness and false-positive results of CA 125 as a tumor marker of ovarian cancer —A study on 674 patients—

M. Kitao, Kentaro Takahashi, O. Iwanari, 1986, The Japanese journal of surgery.

[Differential diagnosis between leiomyomata uteri and adenomyosis using CA 125 as a new tumor marker of ovarian carcinoma].

K. Takahashi, F. Murao, M. Kitao, 1985, Nihon Sanka Fujinka Gakkai zasshi.

Clinical evaluations of the tumor marker sialyl SSEA-1 antigen for clinical gynecological disease.

K. Karino, M. Kitao, O. Iwanari, 1990, Gynecologic and obstetric investigation.

Differential diagnosis of ovarian cancer, benign ovarian tumor and endometriosis by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels.

K. Takahashi, K. Karino, O. Iwanari, 1990, Gynecologic and obstetric investigation.

[Studies on pregnancy after CO2 laser conization for cervical intraepithelial neoplasia].

M. Kitao, O. Iwanari, J. Miyako, 1989, Nihon Gan Chiryo Gakkai shi.